Parameter | Disease-free survival, P valuea |
---|---|
Age | Â |
   <59 vs. ≥59 | 0.031 |
Gender | Â |
   Male vs. female | 0.433 |
CEA mRNA | Â |
   (+) vs. (-) | 0.001 |
Serum CEA | Â |
   (+) vs. (-) | 0.045 |
Histological grade | Â |
   Well/moderately vs. poorly | 0.022 |
pT | Â |
   pTis/pT1 vs. pT2/pT3/pT4 | <0.001 |
pN | Â |
   (+) vs. (-) | 0.001 |
Stage | Â |
   1/2 vs. 3/4 | <0.001 |
Adjuvant chemotherapy agents | Â |
   CAPOX vs. mFOLFOX6 vs. Taxol+DDP vs. Taxol+5Fu/CF | 0.850 |